Market Overview

Excipients in Pharmaceuticals: Global Markets to 2022

Share:

Excipients in Pharmaceuticals: Global Markets to 2022

PR Newswire

LONDON, July 24, 2018 /PRNewswire/ -- Report Scope
This report on the pharmaceutical excipient market covers an overview of excipients, classification of excipients, and their significance in the pharmaceutical industry.A detailed analysis illustrating market dynamics, market structure analysis incorporating Porter's Five Force Framework analysis and supply chain and distribution is discussed in detail.

Download the full report: https://www.reportbuyer.com/product/5476790

Excluded from the scope of this report is the use of excipients in cosmetics, food and beverage, and chemical industries. Emerging pharmaceutical excipients such as co-processed and multifunctional excipients and their impact on the future of pharmaceutical excipients market is also analyzed.

Based on the type of material, the pharmaceutical excipient market is segmented into organic excipients, inorganic excipients and USP Water.Based on route of administration, the pharmaceutical excipient market is segmented by-oral, injectable/parenteral, topical and advanced delivery systems.

By dosage forms, the pharmaceutical excipients market is segmented as solid dosage forms, liquid dosage forms, semi-solid dosage forms, and others (e.g., aerosol and powder). By end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators and others (e.g., academics and pharmacies). This report includes market size estimates for 2016 as the base year, 2017, and forecast estimates for 2022.

Geographically, this report analyzes the market by the following regions: North America, Europe, Asia-Pacific, Latin America and the Middle East. Key countries with a high concentration of pharma manufacturing companies and contract manufacturing organizations, including the U.S., Europe (Germany, U.K., Italy, France and Spain), China, India and Brazil are discussed. A detailed competitive analysis of key leading pharmaceutical excipient suppliers is provided, detailing business operations and segment focus.

Report Includes
- 58 tables
- Detailed analyses of organic and inorganic excipients
- Discussion of various excipient interactions, including drug-excipient interaction, excipient-excipient interaction, and package-excipient interaction
- Insight into the most critical issues surrounding excipients, including technological, regulatory, economic, and political
- Company profiles of major players in the market, including Ashland Global Holdings, Inc., Cargill, Inc, Meggle Pharma Gmbh, The Lubrizol Corporation and Omya Ag

Summary
The global pharmaceutical excipients market reached nearly $REDACTED billion in 2016 and is expected to growat a REDACTED% compound annual growth rate (CAGR) over the next five years, driven by the increase in demand for oleochemicals and petrochemicals, to reach a value of $REDACTED billion in 2022.

Report Scope
This report on the pharmaceutical excipient market covers an overview of excipients, classification of excipients, and their significance in the pharmaceutical industry.A detailed analysis illustrating market dynamics, market structure analysis incorporating Porter's Five Force Framework analysis and supply chain and distribution is discussed in detail.

Excluded from the scope of this report is the use of excipients in cosmetics, food and beverage, and chemical industries. Emerging pharmaceutical excipients such as co-processed and multifunctional excipients and their impact on the future of pharmaceutical excipients market is also analyzed.

Based on the type of material, the pharmaceutical excipient market is segmented into organic excipients, inorganic excipients and USP Water.Based on route of administration, the pharmaceutical excipient market is segmented by-oral, injectable/parenteral, topical and advanced delivery systems.

By dosage forms, the pharmaceutical excipients market is segmented as solid dosage forms, liquid dosage forms, semi-solid dosage forms, and others (e.g., aerosol and powder). By end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators and others (e.g., academics and pharmacies). This report includes market size estimates for 2016 as the base year, 2017, and forecast estimates for 2022.

Geographically, this report analyzes the market by the following regions: North America, Europe, Asia-Pacific, Latin America and the Middle East. Key countries with a high concentration of pharma manufacturing companies and contract manufacturing organizations, including the U.S., Europe (Germany, U.K., Italy, France and Spain), China, India and Brazil are discussed. A detailed competitive analysis of key leading pharmaceutical excipient suppliers is provided, detailing business operations and segment focus.

Report Includes
- 58 tables
- Detailed analyses of organic and inorganic excipients
- Discussion of various excipient interactions, including drug-excipient interaction, excipient-excipient interaction, and package-excipient interaction
- Insight into the most critical issues surrounding excipients, including technological, regulatory, economic, and political
- Company profiles of major players in the market, including Ashland Global Holdings, Inc., Cargill, Inc, Meggle Pharma Gmbh, The Lubrizol Corporation and Omya Ag

Download the full report: https://www.reportbuyer.com/product/5476790

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/excipients-in-pharmaceuticals-global-markets-to-2022-300685682.html

SOURCE ReportBuyer

View Comments and Join the Discussion!